Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDfs Furniture Plc Regulatory News (DFS)

Share Price Information for Dfs Furniture Plc (DFS)

Share Price is delayed by 15 minutes
Get Live Data
121.00    0.00 (0.00%)
Bid:
119.00
Ask:
121.00
Spread: 2.00 (1.681%)
Market Cap: £280.13m
DFS Live PriceLast checked at - London Stock Exchange

Intraday Dfs Furniture Plc Share Chart

Trading Statement

17 Jul 2025 07:00

RNS Number : 3752R
DFS Furniture PLC
17 July 2025
Β 

17 July 2025

Β 

Immediate release

Β 

DFS Furniture plc ("DFS" and the "Group")

Β 

2025 FULL YEAR TRADING UPDATE

Β 

Strong trading and good cost control resulting in PBT(A) slightly above the top end of guidance

Β 

DFS Furniture plc, the market leading retailer of upholstered furniture in the United Kingdom, today issues the following trading update for the 52 week year ending 29 June 2025 ("FY25").

Β 

Summary:

● Full year PBT(A)1 is expected to be slightly above the top end of guidance (Β£25-29m) and up around Β£20m year on year

● Profit performance driven by strong trading, gross margin rate progression and continued cost discipline

● Strong H1 trading performance continued in the second half. H2 Group order intake +10% year on year2 (in line with the growth achieved in H1), demonstrating significant outperformance of the market that remains subdued

● Financial position has further strengthened. Net bank debt reduced to around Β£107m (FY24 year end Β£165m) and leverage3 further reduced to around 1.4x (FY24 year end 2.5x)

Β 

Trading overview:

The Group traded consistently through the period, with order intake up +10% year on year2 in both H1 and H2, supported by volume and average order value growth. Both of our retail brands performed well, with DFS up +8.7% and Sofology up +16.2% year on year2 due to successful implementation of our growth initiatives. Our proprietary data shows the Group has grown market share in the specialist upholstery sector4 in a period where the market remained subdued.

Β 

Gross sales, which are recognised on delivery of orders to customers, were up +5.8% year on year. This is lower than the level of order intake growth (which is measured on a 52 week vs 52 week basis) due to a shift in customer orders to ranges with longer lead times and the impact of the prior year being a 53 week financial reporting period. Consequently, the Group enters FY26 with a resilient order bank.

Β 

We have maintained our focus on disciplined cost management and continued to improve our gross margins. This approach, in combination with the increase in gross sales, has resulted in expected year on year PBT(A)1 growth slightly above the top end of our guidance (Β£25m-Β£29m), up from Β£10.5m (FY24).

Β 

The Group's financial position has improved with net bank debt (excluding capitalised leases) reducing in the period to around Β£107m (FY24 year end Β£165m) and leverage3 reducing to around 1.4x (FY24 year end 2.5x) as we target a return to our 0.5x-1.0x target range.

Β 

The Group will announce its full year results for the period ending 29 June 2025 on 25 September 2025.

Β 

Comment from Tim Stacey, Group Chief Executive

"We are pleased to report that we expect profit for the full year to be slightly above the top end of our guidance. Our excellent first half performance set the foundation for our success, with strong trading through the rest of the year with both our DFS and Sofology brands outperforming the market. We have continued to maintain a strong focus on disciplined cost management and improved our gross margins, leading to significant year on year profit growth. In addition, cash flow was healthy and our balance sheet is strengthening as we progress towards our target leverage range.

Β 

Whilst the macro environment remains challenging our business is in great shape and I would like to thank our amazing colleagues for their support and commitment as we relentlessly focus on delivering against our strategy together. Looking forward, we are confident that the Group is well positioned to drive attractive returns for shareholders as the market recovers and we remain focused on delivering our medium term ambition of Β£1.4bn revenue and 8% PBT margins."

Β 

1 PBT(A): Underlying profit before tax and brand amortisation

2 Full year order intake growth measured on a 52 week vs 52 week basis was 10.2%.

To avoid the distorting impact caused by a different number of winter sale trading days in each trading period H1 YoY order intake growth (+10.1%) has been measured using weeks 1-25 of each trading period. H2 YoY (+10.3%) has been measured using the most comparable 27 weeks.

FY24 was a 53 week reporting period, order intake growth measured on a 52 vs 53 week basis is 8.7% year on year.

3 Banking covenant IAS17 definition

4 Proprietary banking data covering 13 specialist upholstery retailers

Β 

Enquiries:

Β 

DFS (enquiries via Teneo)

Tim Stacey (Group CEO)

Marie Wall (Interim CFO)

Phil Hutchinson (Investor Relations)

investor.relations@dfs.co.uk

Β 

Teneo

James Macey-White

Ayo Sangobowale

+44 (0)20 7353 4200

85fs.dfs@teneo.com

Β 

About DFS Furniture plc

Β 

The Group is the clear market-leading retailer of upholstered furniture in the United Kingdom. Our Group purpose is to bring great design and comfort into every living room, in an affordable, responsible and sustainable manner. We operate an integrated physical and digital retail network of living room furniture showrooms and web sites in the United Kingdom and Republic of Ireland, trading through our leading brands, DFS and Sofology. We attract customers through our targeted and national marketing activities and our reputation for high quality innovative products and services, breadth of product offer and favourable consumer financing options. We fulfil orders for our exclusive product ranges through our own UK finished goods factories, and through manufacturing partners located in the UK, Europe and Far East, and delivered with care through our expert final-mile delivery service "The Sofa Delivery Company Limited".

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFFRDAIRLIE
Date   Source Headline
15th Nov 20247:00 amRNSHolding(s) in Company
31st Oct 20244:35 pmRNSHolding(s) in Company
31st Oct 202412:55 pmRNSHolding(s) in Company
28th Oct 202410:09 amRNSHolding(s) in Company
22nd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSAnnual Financial Report 2024 and Notice of AGM
17th Oct 20247:00 amRNSDirectorate Change
10th Oct 20242:34 pmRNSHolding(s) in Company
9th Oct 20243:16 pmRNSHolding(s) in Company
26th Sep 20241:48 pmRNSDirector/PDMR Shareholding
25th Sep 20247:00 amRNSFY24 Preliminary Results
6th Aug 20243:54 pmRNSHolding(s) in Company
12th Jul 20247:00 amRNSDirectorate Change
24th Jun 202411:45 amRNSHolding(s) in Company
12th Jun 20247:00 amRNSPre Close Trading Statement
3rd Jun 20247:00 amRNSTotal Voting Rights
3rd May 20247:00 amRNSTotal Voting Rights
9th Apr 20247:00 amRNSPost 2023 AGM Shareholder Engagement - Update
8th Apr 20247:00 amRNSHolding(s) in Company
19th Mar 20247:00 amRNSInterim Results
19th Jan 20247:00 amRNSTrading Statement
21st Dec 20233:40 pmRNSHolding(s) in Company
1st Dec 20233:36 pmRNSHolding(s) in Company
15th Nov 202312:36 pmRNSHolding(s) in Company
14th Nov 202312:12 pmRNSHolding(s) in Company
10th Nov 20233:26 pmRNSRESULTS OF AGM
7th Nov 20237:00 amRNSHolding(s) in Company
6th Nov 20237:00 amRNSHolding(s) in Company
20th Oct 202312:14 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
10th Oct 20237:00 amRNSAnnual Financial Report
22nd Sep 202310:13 amRNSDirector/PDMR Shareholding
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSFY23 Preliminary Results
7th Sep 20237:00 amRNS£250M NEW CREDIT FACILITIES SIGNED
17th Jul 20237:00 amRNSTrading Statement
12th Jul 20237:00 amRNSDirector Declaration
9th Jun 20237:00 amRNSDirectorate Change
8th Jun 202310:25 amRNSHolding(s) in Company
3rd May 20239:51 amRNSHolding(s) in Company
21st Apr 20231:54 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim Results
9th Feb 20237:00 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20237:00 amRNSTransaction in Own Shares
20th Jan 20237:00 amRNSTransaction in Own Shares
19th Jan 20237:00 amRNSTransaction in Own Shares
18th Jan 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.